Last mentioned: Mar 6, 2026
2026 NYC Forum
Scheduled date for the Bioelectronic Medicine Forum in New York City.
Forum Announcement
Official announcement of the 2026 Bioelectronic Medicine Forum keynote and presenters.
Astellas Acquisition
Astellas Pharma acquires Iota Biosciences in a deal valued at over $300 million.
Iota Biosciences Founded
Established as a spin-off from UC Berkeley to develop 'neural dust' technology.
The 2026 Bioelectronic Medicine Forum in New York City will feature a keynote from the founder of Iota Biosciences, a leader in miniaturized neural implants. The event highlights a growing international ecosystem of neurotech startups, including Coherence Neuro and Spiro Medical, focused on 'electroceuticals.'
This page surfaces every story mentioning Graphenicalab across our healthcare coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.
Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running healthcare beat. Cross-entity comparisons live on our compare view.
| What you see | What it tells you |
|---|---|
| Story count | Number of distinct stories where Graphenicalab was a primary or referenced actor. |
| Recency clustering | Whether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc). |
| Sentiment distribution | Aggregate sentiment of the stories mentioning this entity, weighted by impact score. |
| Cross-niche links | When the same entity surfaces in our sibling networks, we link to those views to enrich context. |